Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pareto Securities in its capacity as financial advisor in connection with a directed share issue in 24SevenOffice Scandinavia
Mandate

Vinge has advised Pareto Securities in its capacity as financial advisor in connection with a directed share issue in 24SevenOffice Scandinavia

February 03, 2021 Capital Markets and Public M&A

The share issue was directed to a number of Swedish and international institutional investors on the basis of an accelerated bookbuilding process.

The new shares will be issued in two tranches, where the second tranche is subject to approval by the company's extraordinary general meeting to be held on 17 February 2021.Through the share issue, 24SevenOffice will receive SEK 300 million before deduction of transaction costs.

Vinge’s team has consisted of Jesper Schönbeck and Linnéa Sellström.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026